UKF-NB-2rCDDP1000 (Q54990291)

From Wikidata

Jump to navigation Jump to search

cell line

UKF-NB-2 CDDP

Language	Label	Description	Also known as
English	UKF-NB-2rCDDP1000	cell line	UKF-NB-2 CDDP

Statements

1 reference

Cellosaurus release 44

31 January 2023

cancer cell line

1 reference

Cellosaurus release 44

31 January 2023

parent cell line

1 reference

Cellosaurus release 44

31 January 2023

described by source

Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.

1 reference

Cellosaurus release 44

31 January 2023

Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium

1 reference

Cellosaurus release 44

31 January 2023

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.

1 reference

Cellosaurus release 44

31 January 2023

Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs

1 reference

Cellosaurus release 44

31 January 2023

established from medical condition

1 reference

Cellosaurus release 44

31 January 2023

derived from organism type

1 reference

Cellosaurus release 44

31 January 2023

Identifiers

1 reference

Cellosaurus release 44

31 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54990291&oldid=1861775581"